Polar Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-114,000
| Closed | -$7.73M | – | 261 |
|
|
2017
Q1 | $7.73M | Sell |
114,000
-217,220
| -66% | -$14.7M | 0.12% | 157 |
|
|
2016
Q4 | $23.3M | Buy |
331,220
+89,500
| +37% | +$6.29M | 0.37% | 83 |
|
|
2016
Q3 | $17.1M | Buy |
241,720
+236,803
| +4,816% | +$16.8M | 0.3% | 107 |
|
|
2016
Q2 | $240K | Sell |
4,917
-8,315
| -63% | -$406K | ﹤0.01% | 260 |
|
|
2016
Q1 | $838K | Sell |
13,232
-196,768
| -94% | -$12.5M | 0.02% | 240 |
|
|
2015
Q4 | $23.6M | Sell |
210,000
-85,879
| -29% | -$9.63M | 0.43% | 73 |
|
|
2015
Q3 | $28.5M | Buy |
295,879
+33,818
| +13% | +$3.26M | 0.58% | 49 |
|
|
2015
Q2 | $26.8M | Sell |
262,061
-63,467
| -19% | -$6.5M | 0.52% | 59 |
|
|
2015
Q1 | $20.2M | Buy |
+325,528
| New | +$20.2M | 0.38% | 84 |
|